Back to Search
Start Over
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
- Source :
-
European Child & Adolescent Psychiatry . Mar2006, Vol. 15 Issue 2, p105-110. 6p. 2 Diagrams, 1 Chart. - Publication Year :
- 2006
-
Abstract
- Examines the influence of comorbid oppositional defiant disorder (ODD) on the relative risk of relapse in 9 months of treatment for attention-deficit hyperactivity disorder (ADHD). Assessment of placebo treatment effectiveness; Use of atomoxetine for the treatment of ADHD; Occurrence of relapse on ODD.
Details
- Language :
- English
- ISSN :
- 10188827
- Volume :
- 15
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- European Child & Adolescent Psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 19979025
- Full Text :
- https://doi.org/10.1007/s00787-006-0506-y